Degree of health
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
boolean
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
boolean
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
boolean
As a license is needed for use of this questionnaire, the 30 actual questions are not included in this version of the standard set. ICHOM IDs are EORTCQLQC30_Q01 up to EORTCQLQC30_Q30. INCLUSION CRITERIA: All patients TIMING: Baseline, 30 days + annually up to 5 years after index event REPORTING SOURCE: Patient-reported TYPE: Numerical (each question is single answer in original set)
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
integer